Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells

BACKGROUND: The benefit of inducing cellular senescence as a tumor suppressive strategy remains questionable due to the senescence-associated secretory phenotype. Hence, studies and development of senolytic compounds that induce cell death in senescent cells have recently emerged. Senescent cells ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Pungsrinont, Thanakorn, Sutter, Malika Franziska, Ertingshausen, Maren C. C. M., Lakshmana, Gopinath, Kokal, Miriam, Khan, Amir Saeed, Baniahmad, Aria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183592/
https://www.ncbi.nlm.nih.gov/pubmed/32351687
http://dx.doi.org/10.1186/s13578-020-00422-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183592/
https://www.ncbi.nlm.nih.gov/pubmed/32351687
http://dx.doi.org/10.1186/s13578-020-00422-2

Ejemplares similares